{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:46:44Z","timestamp":1783032404895,"version":"3.54.6"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T00:00:00Z","timestamp":1218672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00266-008-9226-7","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T17:04:33Z","timestamp":1218647073000},"page":"654-656","source":"Crossref","is-referenced-by-count":12,"title":["Duration of Correction for Human Immunodeficiency Virus-Associated Lipoatrophy After Retreatment with Injectable Poly-l-Lactic Acid"],"prefix":"10.1007","volume":"33","author":[{"given":"D. R.","family":"Mest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Humble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,14]]},"reference":[{"key":"9226_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2004.08.056","volume":"52","author":"CM Burgess","year":"2005","unstructured":"Burgess CM, Quiroga RM (2005) Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 52:233\u2013239","journal-title":"J Am Acad Dermatol"},{"key":"9226_CR2","first-page":"979","volume":"28","author":"J James","year":"2002","unstructured":"James J, Carruthers A, Carruthers J (2002) HIV-associated facial lipoatrophy. Dermatol Surg 28:979\u2013986","journal-title":"Dermatol Surg"},{"key":"9226_CR3","first-page":"1336","volume":"32","author":"DR Mest","year":"2006","unstructured":"Mest DR, Humble G (2006) Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the U.S. experience. Dermatol Surg 32:1336\u20131345","journal-title":"Dermatol Surg"},{"key":"9226_CR4","unstructured":"Mest DR, Humble G (2008) Efficacy and impact of retreatment with poly-L-lactic acid (PLLA) in persons with human immunodeficiency virus (HIV)-associated facial lipoatrophy (abstract). J Am Acad Dermatol 58(2 suppl 1):AB34"},{"key":"9226_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1468-1293.2006.00342.x","volume":"7","author":"GJ Moyle","year":"2006","unstructured":"Moyle GJ, Brown S, Lysakova L, Barton SE (2006) Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med 7:181\u2013185","journal-title":"HIV Med"},{"key":"9226_CR6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","volume":"5","author":"GJ Moyle","year":"2004","unstructured":"Moyle GJ, Lysakova L, Brown S, Sibtain N, Healy J, Priest C, Mandalia S, Barton SE (2004) A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5:82\u201387","journal-title":"HIV Med"},{"key":"9226_CR7","unstructured":"Sculptra (prescribing information), Dermik Laboratories, a business of Sanofi-Aventis U.S. LLC: Bridgewater, NJ, 2006"},{"key":"9226_CR8","first-page":"542","volume":"3","author":"D Vleggaar","year":"2004","unstructured":"Vleggaar D, Bauer U (2004) Facial enhancement and the European experience with SculptraTM (poly-l-lactic acid). J Drugs Dermatol 3:542\u2013547","journal-title":"J Drugs Dermatol"},{"issue":"suppl 1","key":"9226_CR9","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1111\/j.1529-8019.2007.00103.x","volume":"20","author":"WmP Werschler","year":"2007","unstructured":"Werschler WmP (2007) Advanced injection techniques of poly-L-lactic acid: a case-based presentation. Dermatol Ther 20(suppl 1):S16\u2013S19","journal-title":"Dermatol Ther"},{"key":"9226_CR10","first-page":"385","volume":"3","author":"B Woerle","year":"2004","unstructured":"Woerle B, Hanke CW, Sattler G (2004) Poly-L-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 3:385\u2013389","journal-title":"J Drugs Dermatol"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-008-9226-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00266-008-9226-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-008-9226-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:01:53Z","timestamp":1558717313000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00266-008-9226-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,14]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9226"],"URL":"https:\/\/doi.org\/10.1007\/s00266-008-9226-7","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,14]]}}}